Quality of Life After Novel Coronavirus Infection (Covid-19)
Quality of Life After Novel Coronavirus Infection (Covid-19)
Quality of Life After Novel Coronavirus Infection (Covid-19)
com
International Journal of
CODEN: IJRSFP (USA)
Recent Scientific
International Journal of Recent Scientific Research Research
Vol. 12, Issue, 07 (C), pp. 42363-42367, July, 2021
ISSN: 0976-3031 DOI: 10.24327/IJRSR
Research Article
QUALITY OF LIFE AFTER NOVEL CORONAVIRUS INFECTION (COVID-19)- AN
OBSERVATIONAL STUDY
Simran Kundnani1* and Jalpa Parikh2
1Physiotherapy (Neuroscience), Ahmedabad Institute of Medical Sciences, Gujarat University,
Ahmedabad, Gujarat, India
2Ahmedabad Institute of Medical Sciences, Gujarat University, Ahmedabad, Gujarat, India
DOI: http://dx.doi.org/10.24327/ijrsr.2021.1207.6082
Article History: Objectives: - Coronavirus has put impact on both physical and mental health of the person. It is
th
expected that patients with home isolation or hospital stay for long isolation period due to covid-19
Received 14 April, 2021 infection show reduction in quality of life. So, the aim of study was to find out quality of life after
Received in revised form 29th novel coronavirus infection (COVID-19).
May, 2021 Methodology: 88 subjects with age of 18-35 years were included. To assess quality of life EQ-5D-
Accepted 05th June, 2021 5L Questionnaire was used which include 5 components (mobility, selfcare, usual activities,
Published online 28th July, 2021 pain/discomfort, anxiety/depression)
Results: Slight reduction was seen in overall quality of life in individuals after covid-19 infection.
Key Words: Conclusion: According to this study there is slight reduction in overall quality of life of post covid-
COVID-19, Quality of life, EQ-5D-5L 19 subjects, main component involved are pain/discomfort and anxiety/depression.
Copyright © Simran Kundnani and Jalpa Parikh, 2021, this is an open-access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided
the original work is properly cited.
with specific diseases, and healthcare providers; these studies anxious/depression and 6.7% indicating moderately
have shown an overall decline in QoL, and pronounced anxious/depression.
worsening of anxiety and depression.
In EQ VAS,, out of 88 subjects, 15 subjects have marked score
There is lack of research for Quality of life aspect of post between (85-90)
90) health they can imagine, 36 subjects have
COVID-19 subjects in India, Therefore present study was done marked score between (90-95)
95) health they can imagine, 37
to find out quality of life after novel coronavirus infection subjects have marked score between (95
(95-100) health they can
(COVID-19)
19) with the objectives to assessing overall health imagine.
related quality of life of post COVID-1919 subjects within 2
months with 5 components mobility, selfcare,
selfcare usual activities,
anxiety/depression, pain/discomfort.
MATERIALS AND METHODS
The observational study was performed among 88 subjects of
age 18-35 years with post COVID-19 19 infection (within 2
months), including both male and female and who are
educated.. The study was approved by Ethical review
committee. Random sampling was done.
The exclusion criteria were subjects with immunological
problems like (GBS, multiple sclerosis, psoriasis etc), any other
systematic illness(blood pressure, flu etc), visual and
a hearing
problem.
The materials used were EQ-5D-5L 5L questionnaire it was filled
and submitted through google form and interview method.
Consent form was kept prior filling the questionnaire on google
form. Sample size was calculated according to power analysis.
Outcome measures is EQ-5D-5L.
EQ-5D-5L
The scale comprises of 5 dimensions. Each dimension has 5
levels: no problems, slight problems, moderate problems,
severe problems and extreme problems. The patient is asked to
indicate his/her health statee by ticking the box next to the most
appropriate statement in each of the five dimensions. This
decision results in a 1-digit
digit number that expresses the level
selected for that dimension. The digits for the five dimensions
can be combined into a 5-digit number mber that describes the
patient’s health state.EQ VAS scale is numbered from 0-100. 0
100 means the best health you can imagine and zero means
worst health you can imagine. Mark X on the scale to indicate
how your health is today and then write number you marked
ma on
the scale in the box below. (9)
RESULTS
In the 1st component MOBILITY, 86.4% indicating no
problem, 11.4%indicating slight problem and 2.2% indicating
moderate problem.
In the 2nd component SELF-CARE,84.1% 84.1% indicating no
problem,11.4% indicating slight problem and 4.5% indicating
moderate problem.
In the 3rd component USUAL ACTIVITIES, 73.7% indicating
no problem, 24% indicating slight problem and 2.3% indicating
moderate problem.
In the 4th component PAIN/DISCOMFORT, 61.7% indicating
no pain/discomfort, 34.8% indicating slight pain/discomfort,
2.4% indicating moderate pain/discomfort and 1.1% indicating
severe pain/discomfort.
In the 5th component ANXIETY/DEPRESSION,57.8%
ANXIETY/DEPRESSION,
indicating no anxious/depression, 35.5% indicating
indic slight
42364 | P a g e
International Journal of Recent Scientific Research Vol. 12, Issue, 07 (C), pp. 42363-42367,
42367, July, 2021
42365 | P a g e
Simran Kundnani and Jalpa Parikh., Quality of Life After Novel Coronavirus Infection (COVID-19)- An Observational Study
42366 | P a g e
International Journal of Recent Scientific Research Vol. 12, Issue, 07 (C), pp. 42363-42367, July, 2021
25. Berk M, Williams LJ, Jacka FN, O’Neil A, Pasco JA, 26. Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A,
Moylan S, Allen NB, Stuart AL, Hayley AC, Byrne ML, Gouze H, Doucet L, Berkani S, Oliosi E, Mallart E,
Maes M. So depression is an inflammatory disease, but Corre F. Post-discharge persistent symptoms and health-
where does the inflammation come from?. BMC related quality of life after hospitalization for COVID-
medicine. 2013 Dec;11(1):1-6. 19. Journal of Infection. 2020 Dec 1;81(6):e4-6.
*******
42367 | P a g e